Vardhan launches India's first indigenously developed pneumococcal vaccine 'Pneumosil'

During clinical trials, Pneumosil was found to be safe and effective in the prevention of pneumonia and based on which Pneumosil has been licensed by the Drugs Controller General of India in July 2020 after approval from subject expert committee (SEC), he said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news